JP2011504102A5 - - Google Patents

Download PDF

Info

Publication number
JP2011504102A5
JP2011504102A5 JP2010533308A JP2010533308A JP2011504102A5 JP 2011504102 A5 JP2011504102 A5 JP 2011504102A5 JP 2010533308 A JP2010533308 A JP 2010533308A JP 2010533308 A JP2010533308 A JP 2010533308A JP 2011504102 A5 JP2011504102 A5 JP 2011504102A5
Authority
JP
Japan
Prior art keywords
seq
patient
expression level
antibody
measured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010533308A
Other languages
English (en)
Japanese (ja)
Other versions
JP5730576B2 (ja
JP2011504102A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/082920 external-priority patent/WO2009062125A1/en
Publication of JP2011504102A publication Critical patent/JP2011504102A/ja
Publication of JP2011504102A5 publication Critical patent/JP2011504102A5/ja
Application granted granted Critical
Publication of JP5730576B2 publication Critical patent/JP5730576B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010533308A 2007-11-07 2008-11-07 抗cd40抗体による治療に対するb細胞リンパ腫の応答性を評価するための方法及び組成物 Active JP5730576B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98627707P 2007-11-07 2007-11-07
US60/986,277 2007-11-07
PCT/US2008/082920 WO2009062125A1 (en) 2007-11-07 2008-11-07 Methods and compositions for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013211645A Division JP2014057588A (ja) 2007-11-07 2013-10-09 抗cd40抗体による治療に対するb細胞リンパ腫の応答性を評価するための方法及び組成物

Publications (3)

Publication Number Publication Date
JP2011504102A JP2011504102A (ja) 2011-02-03
JP2011504102A5 true JP2011504102A5 (cg-RX-API-DMAC7.html) 2011-12-15
JP5730576B2 JP5730576B2 (ja) 2015-06-10

Family

ID=40377361

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010533308A Active JP5730576B2 (ja) 2007-11-07 2008-11-07 抗cd40抗体による治療に対するb細胞リンパ腫の応答性を評価するための方法及び組成物
JP2013211645A Pending JP2014057588A (ja) 2007-11-07 2013-10-09 抗cd40抗体による治療に対するb細胞リンパ腫の応答性を評価するための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013211645A Pending JP2014057588A (ja) 2007-11-07 2013-10-09 抗cd40抗体による治療に対するb細胞リンパ腫の応答性を評価するための方法及び組成物

Country Status (11)

Country Link
US (1) US9068230B2 (cg-RX-API-DMAC7.html)
EP (1) EP2222875B1 (cg-RX-API-DMAC7.html)
JP (2) JP5730576B2 (cg-RX-API-DMAC7.html)
KR (1) KR101620642B1 (cg-RX-API-DMAC7.html)
CN (1) CN101910414B (cg-RX-API-DMAC7.html)
AU (1) AU2008323701B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0820707A2 (cg-RX-API-DMAC7.html)
CA (1) CA2704499C (cg-RX-API-DMAC7.html)
IL (1) IL205391A (cg-RX-API-DMAC7.html)
MX (1) MX2010005080A (cg-RX-API-DMAC7.html)
WO (1) WO2009062125A1 (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9075066B2 (en) * 2008-04-21 2015-07-07 Korea Research Institute Of Bioscience And Biotechnology CST1, DCC1, IFITM1 or MELK as markers for diagnosing stomach cancer
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
EP2364368B1 (en) 2008-11-07 2014-01-15 Sequenta, Inc. Methods of monitoring conditions by sequence analysis
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
ES2568509T3 (es) 2009-01-15 2016-04-29 Adaptive Biotechnologies Corporation Perfilado de la inmunidad adaptativa y métodos para la generación de anticuerpos monoclonales
WO2010121231A1 (en) * 2009-04-18 2010-10-21 Genentech, Inc. Methods for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies
CA2765949C (en) 2009-06-25 2016-03-29 Fred Hutchinson Cancer Research Center Method of measuring adaptive immunity
WO2011157678A1 (en) * 2010-06-14 2011-12-22 Qiagen Gmbh Method for determination of target cells or tissue for extraction of biomolecules from fixed biological samples
RU2013140975A (ru) 2011-02-28 2015-04-10 Дженентек, Инк. Биологические маркеры и способы прогнозирования восприимчивости к антагонистам в-клеток
US8592156B2 (en) * 2011-08-08 2013-11-26 Roche Molecular Systems, Inc. Predicting response to anti-CD20 therapy in DLBCL patients
WO2013036459A2 (en) * 2011-09-09 2013-03-14 Sequenta, Inc. Sequence-based measures of immune response
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
HK1201565A1 (en) 2011-10-21 2015-09-04 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
EP3388535B1 (en) 2011-12-09 2021-03-24 Adaptive Biotechnologies Corporation Diagnosis of lymphoid malignancies and minimal residual disease detection
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
US10077478B2 (en) 2012-03-05 2018-09-18 Adaptive Biotechnologies Corp. Determining paired immune receptor chains from frequency matched subunits
PT2831276T (pt) 2012-05-08 2016-07-26 Adaptive Biotechnologies Corp Composições e método para medição e calibração do viés de amplificação em reações pcr multiplex
EP2904111B1 (en) 2012-10-01 2017-12-06 Adaptive Biotechnologies Corporation Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
WO2015160439A2 (en) 2014-04-17 2015-10-22 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
ES2738289T3 (es) 2013-11-06 2020-01-21 Hospital Clinic Barcelona Procedimiento para el subtipado de tipos de linfoma por medio de perfiles de expresión
CA2941612A1 (en) 2014-03-05 2015-09-11 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
JP7054990B2 (ja) 2014-03-27 2022-04-15 ジェネンテック, インコーポレイテッド 炎症性腸疾患の診断及び治療のための方法
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
BR112017008959A2 (pt) 2014-10-29 2018-01-16 Seattle Genetics, Inc. método para tratamento de uma doença.
CA2966201A1 (en) 2014-10-29 2016-05-06 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
EP3498866B1 (en) 2014-11-25 2026-02-25 Adaptive Biotechnologies Corp. Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
WO2016138122A1 (en) 2015-02-24 2016-09-01 Adaptive Biotechnologies Corp. Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing
EP3277294B1 (en) 2015-04-01 2024-05-15 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
EP3329244B1 (en) 2015-07-30 2022-10-05 Qiagen GmbH Method of preparing a frozen biological sample
EP3359688B1 (en) * 2015-10-05 2021-06-16 UCB Biopharma SRL Molecular signatures for use in diagnosis and response to treatment analysis of autoimmune diseases
PL3458074T3 (pl) * 2016-05-16 2024-11-12 Board Of Regents Of The University Of Texas System KOMPOZYCJA DO DOSTARCZANIA tRNA W POSTACI NANOCZĄSTEK I SPOSOBY ICH STOSOWANIA
KR102379464B1 (ko) 2016-06-20 2022-03-29 키맵 리미티드 항-pd-l1 항체
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
CN110402255B (zh) * 2017-04-04 2022-12-02 豪夫迈·罗氏有限公司 新颖的能够特异性结合cd40和fap的双特异性抗原结合分子
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
EP4256087A4 (en) * 2020-12-02 2024-12-04 Albert Einstein College of Medicine METHOD FOR PREDICTING PATIENT RESPONSE TO CD40-TARGETED THERAPIES

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018653A (en) 1971-10-29 1977-04-19 U.S. Packaging Corporation Instrument for the detection of Neisseria gonorrhoeae without culture
US4016043A (en) 1975-09-04 1977-04-05 Akzona Incorporated Enzymatic immunological method for the determination of antigens and antibodies
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4424279A (en) 1982-08-12 1984-01-03 Quidel Rapid plunger immunoassay method and apparatus
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US5182368A (en) 1986-06-13 1993-01-26 Ledbetter Jeffrey A Ligands and methods for augmenting B-cell proliferation
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
EP1690935A3 (en) 1990-01-12 2008-07-30 Abgenix, Inc. Generation of xenogeneic antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
US5874082A (en) 1992-07-09 1999-02-23 Chiron Corporation Humanized anti-CD40 monoclonal antibodies and fragments capable of blocking B cell proliferation
DE69433820T2 (de) 1993-12-23 2005-06-23 Immunex Corp., Seattle Verwendung von löslichen oligomerischen cd40 liganden oder monoklonalen antikörpern zur herstellung eines arzneimitells zur vorbeugung oder behandlung von neoplastischen krankheiten
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
GB9425060D0 (en) 1994-12-13 1995-02-08 Univ Birmingham Carcinoma treatment
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
DE19544393A1 (de) 1995-11-15 1997-05-22 Hoechst Schering Agrevo Gmbh Synergistische herbizide Mischungen
EP1972194A1 (en) 1996-12-03 2008-09-24 Amgen Fremont Inc. Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
US6737056B1 (en) 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
US6946129B1 (en) 1999-06-08 2005-09-20 Seattle Genetics, Inc. Recombinant anti-CD40 antibody and uses thereof
US6248535B1 (en) 1999-12-20 2001-06-19 University Of Southern California Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
CA2402525A1 (en) 2000-03-31 2001-10-11 Genentech, Inc. Compositions and methods for detecting and quantifying gene expression
WO2001083755A2 (en) 2000-04-28 2001-11-08 La Jolla Institute For Allergy And Immunology Human anti-cd40 antibodies and methods of making and using same
JP4679035B2 (ja) 2001-04-02 2011-04-27 ジェネンテック, インコーポレイテッド 併用療法
JP4025881B2 (ja) * 2001-04-27 2007-12-26 キリンファーマ株式会社 抗cd40モノクローナル抗体
AR039067A1 (es) 2001-11-09 2005-02-09 Pfizer Prod Inc Anticuerpos para cd40
WO2004071572A2 (en) * 2003-02-06 2004-08-26 Genomic Health, Inc. Gene expression markers for response to egfr inhibitor drugs
US7767387B2 (en) * 2003-06-13 2010-08-03 Sagres Discovery, Inc. Therapeutic targets in cancer
US7711492B2 (en) * 2003-09-03 2010-05-04 The United States Of America As Represented By The Department Of Health And Human Services Methods for diagnosing lymphoma types
PL1682177T3 (pl) 2003-11-04 2011-03-31 Novartis Vaccines & Diagnostics Inc Zastosowanie antagonistycznych przeciwciał anty-CD40 do leczenia przewlekłej białaczki limfocytowej
AU2004287879C1 (en) * 2003-11-04 2011-05-26 Novartis Vaccines And Diagnostics, Inc. Antagonist anti-CD40 monoclonal antibodies and methods for their use
CA2563074C (en) 2004-04-09 2014-05-20 Genomic Health, Inc. Gene expression markers for predicting response to chemotherapy
WO2006044294A2 (en) 2004-10-14 2006-04-27 Eli Lilly And Company Human protein c analogs
EP2312315A1 (en) * 2005-05-18 2011-04-20 Novartis AG Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component
AU2006247067B2 (en) 2005-05-18 2012-06-07 Novartis Ag Methods for diagnosis and treatment of proliferative disorders mediated by CD40 signaling
JP5027804B2 (ja) 2005-05-26 2012-09-19 シアトル ジェネティクス,インコーポレーテッド ヒト化抗cd40抗体およびその使用方法
EP2687608B1 (en) 2005-06-08 2017-02-08 Millennium Pharmaceuticals, Inc. Methods for the identification, assessment, and treatment of patients with cancer therapy
EP1943523A2 (en) 2005-09-16 2008-07-16 Biovator Technologies AB In vitro assay for identification of allergenic proteins
DE102005052384B4 (de) 2005-10-31 2009-09-24 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Erkennung, Markierung und Behandlung von epithelialen Lungentumorzellen sowie Mittel zur Durchführung des Verfahrens
US7527774B2 (en) 2005-12-22 2009-05-05 Basf Catalysts Llc Inlet metallic foam support coupled to precious metal catalyst for application on 4 stroke platforms
US20090075272A1 (en) 2006-01-20 2009-03-19 Hollmann C Annette Method to Identify CD40-Sensitive Cells Using Gene Expression
WO2008079269A2 (en) 2006-12-19 2008-07-03 Genego, Inc. Novel methods for functional analysis of high-throughput experimental data and gene groups identified therfrom
WO2010121231A1 (en) 2009-04-18 2010-10-21 Genentech, Inc. Methods for assessing responsiveness of b-cell lymphoma to treatment with anti-cd40 antibodies

Similar Documents

Publication Publication Date Title
US7332280B2 (en) Classification of patients having diffuse large B-cell lymphoma based upon gene expression
KR101562644B1 (ko) 직장결장암용 예후 예측
EP2909606B1 (en) Device and methods of using device for detection of aminoacidopathies
JP2012523838A5 (cg-RX-API-DMAC7.html)
JP2006517093A5 (cg-RX-API-DMAC7.html)
JP6998658B2 (ja) アミノ酸代謝異常の検出のためのデバイス、及びデバイスを使用する方法
WO2014075083A1 (en) Methods for predicting age and identifying agents that induce or inhibit premature aging
JP2008536488A5 (cg-RX-API-DMAC7.html)
JP2012526554A5 (cg-RX-API-DMAC7.html)
JP2014509868A5 (cg-RX-API-DMAC7.html)
RU2011141497A (ru) Способ применения axl в качестве маркера эпителиально-мезенхимального перехода
CA2735129A1 (en) Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation
CA2795554A1 (en) Gene-expression profiling with reduced numbers of transcript measurements
CN115198019A (zh) 一种与头颈鳞状细胞癌放疗敏感性相关的预后标志物、预后及放疗风险评估方法的应用
JP2008512984A5 (cg-RX-API-DMAC7.html)
Goulter et al. Evaluation of low density array technology for quantitative parallel measurement of multiple genes in human tissue
RU2011134644A (ru) Способы определения восприимчивости пациента к внутрибольничной инфекции и составления прогноза развития септического синдрома
Sun et al. Capture and detection of nucleic acid aptamer target proteins in colorectal cancer
CN106636441A (zh) 一种检测aldh2基因突变的探针及其应用和试剂盒
CN108426932B (zh) 一种基于三链连环dna的电化学生物传感器及制备方法
WO2020021028A1 (en) Biomarkers for the diagnosis and/or prognosis of frailty
Russell et al. Host gene expression changes in cattle infected with Alcelaphine herpesvirus 1
CN1764727A (zh) 确定肿瘤分化等级的方法
CA2894660C (en) Method and apparatus for detecting cancer in mammals
CN109402256B (zh) 利用多个免疫调控点分子的表达量评价胶质瘤临床预后的系统